Trial of High-dose Urso in Primary Sclerosing Cholangitis

NCT00059202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

150

Enrollment

NIH

Sponsor class

Stopped DSMB reviewed interim analysis and terminated the study due to futility.

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG: Ursodeoxycholic Acid
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)